Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Computational Algorithms Could Transform COVID-19 Diagnosis and Care, Finds Study

By HospiMedica International staff writers
Posted on 11 Jan 2022

Researchers testing the effectiveness of algorithms in diagnosing COVID-19 have found that they can help to stem the spread of the disease by enabling early identification of new cases. More...

The study conducted by researchers at the University of Eswatini (Kwaluseni, Eswatini) found that computational algorithms could transform COVID-19 diagnosis and care for low-income countries.

With the emergence of new COVID-19 variants, and infections continuing to rise, effective diagnostic software systems are urgently required to support the increasingly overstretched virus testing services. In addition, these software systems can help to stem the spread of COVID-19 by enabling early identification of new cases. This can be particularly important in low-income countries where medical personnel and facilities are limited.

Computational algorithms can also play a valuable role in identifying cases that traditional clinical diagnosis methods may miss; for example, infections in people with certain underlying diseases. While artificial intelligence models are already available to support diagnosis of COVID-19, most are used in interpreting X-ray image data; and are not always effective in early-stage diagnosis, when the patient’s respiratory and cardiovascular systems may show few signs of the virus.

In the study, the researchers tested the ability of seven computational algorithms to diagnose COVID-19 at an early stage, based on the following common symptoms: fever or chills; cough; shortness of breath or difficulty breathing; fatigue; muscle or body aches; headache; loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; and diarrhea. The researchers found that the algorithms Multilayer Perceptron, Fuzzy Cognitive Map and Deep Neural Network outperformed Logistic Regression, Naïve Bayes, Decision Tree and Support Vector Machine. The researchers believe that these findings could guide future software development.

“This information could be adopted to develop intelligence-based software that both medical personnel and patients can use for early diagnosis of COVID-19 when these symptoms are present. At the time we were conducting this research, we could not find any other studies that had applied any of the listed intelligent techniques for COVID-19 diagnosis using these common symptoms,” said Boluwaji A. Akinnuwesi, an Associate Professor in the Department of Computer Science at University of Eswatini. “Using these algorithms is a better option than exposing patients to X-rays, which, in addition, are not always easily accessible. The three best performing algorithms have the potential to be developed into widely-available software, increasing access to quick and affordable diagnosis of COVID-19 infection, which is particularly important for low-income countries, like Africa.”

Related Links:
University of Eswatini


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.